HEXO Is Surging Ahead of Earnings: Should You Be Buying?

 HEXO Corp (TSX:HEXO)(NYSE:HEXO) is releasing its quarterly results later this week, which will be a big test for the company.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

It could be a big week for HEXO (TSX:HEXO)(NYSE:HEXO), as the pot producer releases its third-quarter earnings on Thursday before the markets open. Shares of the company have been soaring over the past month, as they’re up more than 70%. On Monday, the stock was up more than 20% by midday. Here’s how it’s done of late compared to its peers:

HEXO Chart

The stock’s been performing very well recently, but over the past year the results tell a bit of a different story:

HEXO Chart

What can we attribute these gains to?

The markets as a whole have been fairly bullish over the past few weeks. There’s been growing optimism, as cities in North America have been reopening. There’s hope that the COVID-19 pandemic may not have as disastrous an impact on the economy as once feared. And for stocks like HEXO that have incurred significant losses over the past year, it’s made them more attractive buys in the process. After all, if the economy’s doing better, then there will be more consumers making discretionary purchases, and that means more pot buying.

But where the stock goes from here will largely depend on how it does in its upcoming earnings release.

What investors should look for when the company releases earnings

HEXO has incurred a loss in each of its last 10 quarterly results. It would be nothing short of shocking if the company were to post a profit, especially since in its last quarter it had a mammoth $298 million loss. That was due to some sizeable writedowns that weighed the company’s bottom line down. However, HEXO had a negative gross margin, so profitability wasn’t going to happen with or without the writedowns.

It’s a given that HEXO will occur a loss in its third quarter; the only question is how big it will be.

The one thing investors should keep an eye out for is impairments and whether they reoccur, and if so, to what degree? Another series of large writedowns could send the stock crashing despite its recent gains. Another area investors will want to look for is whether HEXO’s growing its sales — something that hasn’t been an automatic in the cannabis industry this year. HEXO’s value brand should help take revenue away from the black market, but it may not be enough to offset the downturn that COVID-19 may have caused in recent months.

Is HEXO a buy?

Investors are taking on a big risk when buying a stock that’s rallying significantly heading into earnings. It’s a sign that there’s a lot of excitement heading into earnings, and that also means expectations will be high for the company to do well. Canopy Growth didn’t post impressive sales numbers when it released its most recent earnings, and that was even as the industry saw lots of panic buying in March. HEXO’s earnings will go until the end of April when panic buying slowed.

Despite HEXO’s decline over the past year, there are more reasons to expect a poor showing in Q3 than there are that the company will beat expectations. And that’s why I wouldn’t get on the bandwagon, especially as the stock’s near its three-month high. Investors could incur significant losses if the company doesn’t post an amazing performance this week.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »